Adverse predictive value of ASPM on lung adenocarcinoma overall survival depended on chemotherapy status
ASPM exhibits a dual role in LUAD prognosis, acting as a marker for improved chemotherapy outcomes while promoting tumor proliferation. These findings underscore ASPM's potential as a therapeutic target and predictive marker for personalized treatment in LUAD.
Authors
- Baichen Sun
- Zhiling Qu (ORCID: https://orcid.org/0009-0003-2535-6708)
- Yan Zheng (ORCID: https://orcid.org/0000-0002-6891-1252)
Institutions
- First Affiliated Hospital of Xiamen University (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Future Science OA
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1080/20565623.2025.2489328
- Citations
- 1
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.94